Peptide Initiative

Peptide history · 1995

Cathelicidin Antimicrobial Peptide Family

Ancient immune warriors living in every animal's white blood cells.

Clinical Trials1985 – 2024

Cathelicidins are defense peptides found in all mammals, birds, reptiles, and fish. Every animal has its own versions, but they all share a cathelin structure. They fight bacteria by punching holes in cell walls.

Every vertebrate speciesFound Everywhere

Humans, pigs, cattle, mice, fish, chickens, frogs all have cathelicidins.

Only 1 (LL-37)Human Version

We have just one cathelicidin. Pigs have over 10 different versions.

1995Official Discovery

Scientists realized they all share a cathelin-like structure and named the family.

Boosts powerVitamin D Connection

Works with vitamin D from sunlight to fight tuberculosis and infections.

Cathelin proteinNamed After

Called cathelicidins because the domain resembles cathelin from pig immune cells.

1995Discovery Year

When this peptide was first identified

  • Margherita Zanetti

    Family Namer · University of Trieste, Italy

    Named the cathelicidin family in 1995. Realized all family members share a cathelin-like domain. Created the term that scientists still use today.

    These peptides share a common structural feature. Let us call them cathelicidins.
  • Gennaro Romeo

    Discovery Leader · University of Trieste, Italy

    Led the research team that discovered bovine cathelicidins come from larger precursor proteins. Found that different cow peptides were actually related cousins.

    They all share the same structural blueprint, just different antimicrobial blades.
  • Ranieri Ritonja

    Cathelin Discoverer · University of Trieste, Italy

    Identified cathelin in pig proteins in 1989. This discovery inspired the family name. His work was the key connection piece.

    This pig protein holds the key to understanding the entire family.
  • Robert Lehrer

    Antimicrobial Expert · UCLA, USA

    Leading researcher on antimicrobial peptides. Studied how cathelicidins attack bacteria. Showed how LL-37 works against infections.

    These peptides represent nature's original antibiotic defense.

  1. The Discovery

    The Puzzle Begins

    Strange Peptides in Cow Blood

    Key moment

    Bac5 becomes first known cathelicidin member

    In the 1980s, researchers studied white blood cells from cows and discovered something odd. Different antimicrobial peptides seemed to come from the same cell type but looked completely unrelated. Scientists named them Bac5, Bac7, and Lf-B30.

    Each one could kill bacteria. But they seemed like separate discoveries. No one realized they were cousins in one big family. It was like finding different tools in a toolbox but not recognizing they all came from the same company.

    The mystery deepened. Why did cows produce so many different antimicrobial peptides? What connected them? Scientists were puzzled.

  2. The Breakthrough

    The Breakthrough

    A Hidden Connection Found

    Key moment

    Common cathelin structure identified across all members

    In 1989, scientist Ranieri Ritonja discovered a pig protein called cathelin. It was inside larger precursor proteins. Then Gennaro Romeo's team realized something incredible.

    All those strange cow peptides shared the same structure as cathelin! They all started with a cathelin-like section attached to a unique antimicrobial part. The pieces clicked together. These weren't separate peptides. They were all the same family.

    It was like recognizing that different model cars all came from the same factory. The frame was the same (cathelin), but the engines were different. Romeo's team published their findings. Other scientists started looking at animals everywhere.

  3. The Trials

    Giving the Family a Name

    The Cathelicidin Family is Born

    Key moment

    Zanetti coins term 'cathelicidin' for unified family

    Margherita Zanetti and her colleagues coined the term cathelicidin in 1995. They said, 'We should call this entire family cathelicidins because they all have cathelin-like domains.'

    Scientists looked everywhere. Pigs had PR-39 and protegrins. Cattle had BMAP-27 and BMAP-28. Humans had LL-37. Mice had CRAMP. Fish had their own versions. Even chickens and frogs had cathelicidins. Every animal studied had at least one.

    Each was shaped differently but built on the same blueprint. It was one of the biggest discoveries in immunology. A whole family had been hiding in plain sight all along.

  4. The Crisis

    Decoding the Secret

    How They Work

    Key moment

    Mechanism understood: release, cutting, and bacterial attack

    Scientists discovered cathelicidins work like tiny arrows made of amino acids. The cathelin domain was just packaging. When white blood cells released these peptides, special scissors (proteases) cut off the cathelin part.

    This left the sharp antimicrobial blade. The blade punched holes in bacterial cell membranes. Some cathelicidins like PR-39 from pigs worked differently. They snuck inside bacteria and stopped them from making new DNA. By 2000, researchers realized cathelicidins also talked to vitamin D.

    Together they fought tuberculosis and serious infections. Scientists in 2007 proved that vitamin D directly increases cathelicidin production. This explained why sun-exposed populations have fewer TB infections.

  5. The Legacy

    From Laboratory to Clinic

    Future Battles Ahead

    Key moment

    LL-37 enters human clinical trials

    Today, cathelicidin research has exploded. Scientists test them against antibiotic-resistant superbugs. Human LL-37 entered clinical trials in 2020 for wound healing and infection control. Drug companies engineer enhanced versions based on pig PR-39 and other animal models.

    Some see cathelicidins as humanity's ancient immune software. This system has been in every creature for millions of years. It's waiting to be weaponized against modern threats like resistant bacteria. The family that seemed like separate discoveries now looks like evolution's greatest gift to survival.

    Future treatments may include topical creams for acne and eczema. Inhalable versions could fight lung infections. Genetic testing might reveal which cathelicidins each person produces best.

14 milestones, 1985 – 2024.

  1. 1985First cathelicidin, Bac5, discovered in bovine neutrophils
  2. 1989Cathelin protein identified in pig white blood cells
  3. 1992LL-37 (human cathelicidin) formally identified and named
  4. 1993Romeo group reports bovine peptides share cathelin-like structure
  5. 1995Zanetti coins term 'cathelicidin' for entire peptide family
  6. 1995Porcine cathelicidins synthesized and tested against bacteria
  7. 2000Cathelicidins identified in mice and connected to vitamin D
  8. 2005PR-39 shown to enter bacterial cells and disrupt DNA
  9. 2007Vitamin D-mediated immunity against TB depends on cathelicidin
  10. 2010Cathelicidin found in reptiles, amphibians, and fish
  11. 2015Duck cathelicidin studied, showing diversity within species
  12. 2020LL-37 enters human clinical trials for wound healing
  13. 2023Vitamin D and cathelicidin combination crucial for TB prevention
  14. 2024Cathelicidins explored as antibiotic alternatives

Cathelicidins are proteins made from chains of amino acids. Each one has two main parts: a cathelin domain and an antimicrobial peptide. The cathelin acts like a handle or protective cover. The antimicrobial peptide is the sharp blade that fights germs.

Molecular structure

Human Version (LL-37)
37 amino acids
Key Feature
Cathelin pro-domain
Charge
Positively charged
Shape
Alpha helix (spiral)

1Cathelicidins in humans

Humans have only one cathelicidin (LL-37), also called hCAP-18.

10+Cathelicidins in pigs

Pigs have over 10 different versions, including PR-39 and protegrins.

25+Animal species studied

Scientists have found cathelicidins in 25 or more animal species.

37Amino acids in LL-37

The 'LL' means two leucine amino acids at the start of the chain.

1995Official family naming

Year Zanetti and colleagues officially named the cathelicidin family.

500 million yearsFamily age estimate

Cathelicidins appear in fish, so they evolved that long ago.

Real stories, real lives

  • Anna

    Anna had a diabetic foot wound that would not heal for three years despite multiple antibiotics. In a clinical trial, LL-37 peptide treatment triggered new blood vessel growth. Within eight weeks, the wound showed significant healing for the first time.
  • Marcus

    Marcus had repeat Staphylococcus infections becoming antibiotic-resistant. Doctors found his LL-37 levels were unusually low. After vitamin D supplements increased his cathelicidin production, his infections stopped recurring for over a year.
  • Elena

    Elena's sister contracted tuberculosis and Elena had close contact. Her doctor prescribed vitamin D to boost cathelicidin production. Elena never developed TB, suggesting the enhanced immune defense worked.

The future of Cathelicidin (hCAP-18 / Synthetic Derivatives)

  • Engineered Super-Cathelicidins5-10 years away

    Scientists will combine PR-39 efficiency with LL-37 safety. Tested against resistant bacteria.

  • Topical Peptide Creams3-5 years away

    Over-the-counter skin products with cathelicidins for acne, eczema, and minor wounds.

  • Antibiotic Combination Therapy5-8 years away

    Mixing cathelicidins with traditional antibiotics to overcome resistance.

  • Inhalable Formulations for Lungs8-12 years away

    Delivering cathelicidins to lungs for tuberculosis and cystic fibrosis infections.

  • Personalized Immune Profiles10+ years away

    Genetic testing reveals which cathelicidins each person makes best.

Be inspired

The story of Cathelicidin (hCAP-18 / Synthetic Derivatives) is ultimately about the relentless pursuit of better medicine for humanity.

Continue the legacy. The next breakthrough could be yours.

Cathelicidin (hCAP-18 / Synthetic Derivatives) Chronicles. Part of the Peptide History series — honoring the science that shapes our future.

This content is for educational purposes only and should not be considered medical advice.